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ABSTRACT
Kallmann syndrome (KS) consists of congenital, isolated, idio-
pathic hypogonadotropic hypogonadism (IHH) and anosmia. The gene
responsible for the X-linked form of KS, KAL, encodes a protein,
anosmin, that plays a key role in the migration of GnRH neurons and
olfactory nerves to the hypothalamus. In addition to X-linked pedi-
grees, autosomal dominant and recessive kindreds with KS have been
reported. The relative importance of these autosomal vs. X-linked
genes in producing KS, and the frequency of KAL mutations, are
currently unknown because these are rare disorders and large series
are unusual.
We examined 101 individuals with IHH (6 anosmia) and their
families to determine their modes of inheritance, incidence of muta-
tions in the coding sequence of KAL, genotype-phenotype correlations,
and [in a subset (n 5 38)] their neuroendocrine phenotype.
Of the 101 patients, 59 had true KS (IHH 1 anosmia/hyposmia);
whereas, in the remaining 42, no anosmia was evident in the patients
or their families. Of the 59 KS patients, 21 were familial, whereas 38
were sporadic cases. Mutations in the coding sequence of KAL were
identified in only 3 of 21 familial cases (14%) and 4 of 38 (11%) of the
sporadic cases. Of the X-linked cases confirmed by mutational anal-
ysis, only 1 of 3 pedigrees appeared X-linked by inspection whereas
the other 2 contained only affected brothers. Female members of
known KAL mutation families (n 5 3) exhibited no reproductive
phenotype and were not anosmic, whereas families with anosmic
women (n 5 3) were not found to carry mutations in KAL. Mutations
were uniformly absent in nonanosmic IHH probands (n 5 42), as well
as in families with both anosmic and nonanosmic members (n 5 2).
Overall, 4 novel mutations were identified (C172R, R1913, R4573,
and delC@L600).
With respect to neuroendocrine phenotype, KS men with docu-
mented KAL mutations (n 5 8) had completely apulsatile LH secre-
tion, whereas those with autosomal modes of inheritance demon-
strated a more variable spectrum with evidence of enfeebled (but
present) GnRH-induced LH pulses.
Our conclusions are: 1) Confirmed mutations in the coding se-
quence of the KAL gene occur in the minority of KS cases, i.e. only 14%
of familial and 11% of sporadic cases; 2) The majority of familial (and
presumably sporadic) cases of KS are caused by defects in at least two
autosomal genes that are currently unknown; 3) Obligate female
carriers in families with KAL mutations have no discernible pheno-
type; 4) KAL mutations are uniformly absent in patients with either
normosmic IHH or in families with both anosmic and nonanosmic
individuals; and 5) Patients with KAL mutations have apulsatile LH
secretion consistent with a complete absence of GnRH migration of
GnRH cells into the hypothalamus, whereas evidence of present (but
enfeebled) GnRH-induced LH pulses may be present in autosomal KS
cases. Taken together, these findings suggest that autosomal genes
account for the majority of familial cases of KS, and that unique
neuroendocrine phenotypes consistent with some GnRH neuronal
migration may exist in these patients. (J Clin Endocrinol Metab 86:
1532–1538, 2001)
IN 1944, KALLMANN first described the clinical associa-tion of hypogonadotropic hypogonadism and anosmia
(1) that has been classified as Kallmann syndrome (KS) ever
since. In 1992, the first genetic defect in the KAL gene in Xp
22.3 was described (2); and the physiology and developmen-
tal biology of the protein it encodes, anosmin, is undergoing
characterization (3). In the X-linked form, KS is characterized
by a failure of hypothalamic GnRH secretion caused by a
migratory defect of GnRH neurons from the olfactory pla-
code to the hypothalamus (4). In addition, the associated
anomalies of unilateral renal agenesis and synkinesia have
been suggested to be specific to the X-linked form (5–7).
These phenotypic abnormalities seem to have correlates in
the developmental pattern of KAL gene transcripts in the
chick embryo (8).
However, in the human, KS is characterized by consider-
able clinical and genetic heterogeneity. Families have been
documented with individuals having full KS, normosmic
idiopathic hypogonadotropic hypogonadism (IHH), and iso-
lated anosmia within a single sibship (9). To shed further
light on this heterogeneity, we examined a broad spectrum
of patients with IHH, with and without anosmia, to deter-
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mine their clinical spectrum, modes of inheritance, incidence
of mutations in the coding sequence of KAL, and neuroen-
docrine phenotypes.
Our results demonstrate that autosomal genes are clearly
responsible for the majority of both familial and sporadic KS
and that these cases have clinical and neuroendocrine phe-
notypes that distinguish them from the X-linked form.
Subjects and Methods
Experimental subjects
One hundred and one probands with IHH were evaluated. In all
patients, complete IHH was documented based on the following pre-
viously published criteria: age more than 18 yr; clinical signs and symp-
toms of hypogonadism; prepubertal testosterone (,100 ng/dL) and
estradiol levels (,20 pg/mL); low or inappropriately normal gonado-
tropin levels; normal baseline and reserve testing of other anterior pi-
tuitary hormones; and normal radiological imaging of the hypothalam-
ic-pituitary region (10). Patients were questioned as to their ability to
smell, because the subjective reporting of anosmia has proven a reliable
marker of this symptom (9).
Modes of inheritance. Genetic criteria were used to establish the likely
mode of disease transmission as outlined in previous analyses (9). A
family was classified as X-linked if only males were affected and un-
affected females could be considered carriers. There could be no male-
to-male transmission. A family was considered autosomal dominant if
direct transmission of the phenotype was demonstrable across gener-
ations. Male-to-male transmission was considered definitive evidence
for dominant inheritance. A family was classified as autosomal recessive
if all affected individuals were members of the same generation and
included at least one female. Consanguinity provided additional sup-
port for this designation. Delayed puberty and isolated anosmia were
used as surrogate markers of the phenotype (9).
Despite these basic genetic criteria, it is not always possible to cor-
rectly distinguish between different modes of genetic transmission. For
example, a nonpenetrant, dominant genetic trait may be expressed in a
male grandparent and a male child but not in a female parent, thereby
appearing X-linked. In addition, heterozygous female carriers with par-
tial expression have been documented in numerous X-linked disorders.
Finally, kindreds with only affected brothers within a single sibship may
represent any of the major modes of genetic inheritance, including
dominant, recessive, and X-linked forms (for the purposes of this study,
these latter kindreds were labeled as indeterminate). Therefore, recog-
nizing these ambiguities, the best effort was made to classify families
appropriately, with the knowledge that the KAL mutation analysis per-
formed in this study would provide additional clarification.
Methods and materials
Mutation detection. Mutation detection was carried out by multiple meth-
ods of analysis. In the first method, a sequence polymorphism, located
8.7 kb downstream from the 39 end of the KAL gene, was used (11) to
examine the possibility of association of this locus with IHH in affected
individuals of four families. Other DNA samples were analyzed using
temperature gradient gel electrophoresis (TGGE) or single-stranded
conformational polymorphism (SSCP) on PCR products generated with
exon-specific primers based on adjacent intronic sequences. All abnor-
malities discovered by TGGE and SSCP screening were confirmed by
direct sequencing.
Genomic DNA was extracted from peripheral blood leukocytes using
standard procedures (12). PCR oligonucleotide primers were based on
those published by Hardelin et al. (5) or designed using Lasergene
software (DNASTAR Inc., Madison, WI). The latter primers are: exon 1:
59CGCGGCGGCTGCCTGGTCCTC39 (forward) and 1: 59GGCCGCAG-
CCCC-AGAAAGAACC39 (reverse); exon 2: 59TTAAAGTAGAAATCT-
GTGTATGTG39 (forward); exon 7.1: 59ATGCACAGGGATGTCCG-
GCTC39 (reverse); exon 7.2: 59CAACAGTGATGGGAGT GTGAC39 (for-
ward); exon 8: 59TCTCCCTCCATTGTGCCTTGTTGTGAT39 (reverse);
exon 9.1: 59ACTTGCAGTTGGCCATCCTGA39 (reverse); exon 9.2:
59AGAAAAGGTGGAATTCAAACA39 (forward); exon 11.1: 59TTGCT-
AGCATAATTCTCTTTCTCTTG39 (forward); exon 11.1: 59TTCCCCT-
TAAGAGCAGAGCAT39 (reverse); exon 11.2: 59TCCTGCAAGTAT-
AAG G T GACTGTCCA39 (forward); exon 13: 59GCCTGGAATA-
GAATCTAGTAAGTC39 (reverse); exon 14: 59AGGGTCTCGTGCTTTT-
TCTACAAAT39 (forward). A 40-base GC-clamp was incorporated on
the 59-end of either the forward or reverse primer to increase the sen-
sitivity of the TGGE technique (13, 14).
Before TGGE, the theoretical melting temperature of the predicted
PCR product corresponding to each pair of primers was determined
using WinMelt software (Bio-Rad Laboratories, Inc., Hercules, CA).
These predictions allowed the optimization of primer design for each
particular exon. Exons 7, 9, and 11 were each divided into two over-
lapping segments (i.e. exons 7.1 and 7.2) that were independently am-
plified in different reactions because computer analyses indicated that
these full-length exons would not yield the uniform melting curves
required for TGGE.
PCR reactions were performed in a vol of 100 mL containing 50 pmol
of each PCR primer, 200 mmol of each deoxynucleotide triphosphate,
2.5U Taq polymerase, 10 mmol/L Tris-HCl (pH 8.3), 1.5 mmol/L MgCl2,
50 mmol/L KCl, 0.01% gelatin, and 200 ng genomic DNA. Amplification
of exon 1 was carried out in the presence of 8% dimethylsulfoxide. PCR
was performed in a Gene Amp 9600 system (Perkin-Elmer Corp., Foster
City, CA) using 35 cycles. DNA was denatured at 95 C for 5 min in the
first cycle and for 30 sec in all subsequent cycles. Annealing was per-
formed at 53–69.7 C for 30 sec, depending on the exon. Elongation was
performed at 72 C for 30 sec, with a final elongation of 10 min. Ampli-
fication was confirmed by agarose gel electrophoresis.
TGGE. Samples were analyzed, as previously described, using a TGGE
apparatus (Diagen, Du¨sseldorf, Germany) (15). The temperature gradi-
ent, running time, position of the loading wells for parallel TGGE, and
gel concentration were established by diagonal TGGE of each PCR
product. Each product was examined in the absence and presence of a
similar amplified segment from a healthy volunteer to look for abnormal
patterns. PCR products that revealed a heteroduplex or mutant homo-
duplex were ethanol-precipitated and sequenced (500-ng DNA tem-
plate/reaction) on an ABI200 377 automated DNA sequencer (Perkin-
TABLE 1. Patient population by diagnosis, mode of inheritance, and neuroendocrine studies
101 Probands with hypogonadotropic hypogonadism screened for KAL mutations
Anosmia Yes; n 5 59 with KS No; n 5 42 with IHH
Inheritance Sporadic n 5 38 Familial n 5 21 Sporadic n 5 23 Familial n 5 13
KAL Mutations 4 1/1 X-L 0 0/1 X-L
2/6 Indeterminate 0/1 Indeterminate
0/8 AD 0/4 AR
0/6 AR 0/7 AD
Neuroendocrine studies KAL gene KAL gene
NL Mutant NL Mutanta
n 5 10 n 5 2 n 5 2 n 5 7 n 5 16 n 5 0
Apulsatile LH 7 2 1 7 10 0
Low Amplitude LH 3 0 1 0 6 0
a Patients with novel mutations as described in this study (n 5 3) and patients previously described by our group (n 5 4) (19).
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Elmer Corp.). Positive controls created by PCR-directed mutagenesis
(16, 17) were included on each gel to optimize the TGGE gel conditions
and check the sensitivity.
SSCP. SSCP was performed, as previously described (18), for exon 4
because of difficulties in optimizing the condition for this exon on the
TGGE apparatus. PCR was performed with the inclusion of 32P deoxy-
ATP. Twenty microliters of PCR product was mixed with 0.06% SDS,
heated at 90 C for 3 min, and rapidly chilled on ice. Four microliters of
each sample was loaded onto a 6% acrylamide gel with 10% glycerol
(49:1 acrylamide to bisacrylamide) and run at 4 C for 14 h at 6 V. The
gel was dried and exposed to x-ray film (Biomax MS, Eastman Kodak
Co., Rochester, NY) at 280 C for 1 h.
Pulsatile LH secretion. Thirty-seven patients were admitted to the General
Clinical Research Center of the Massachusetts General Hospital for
overnight blood sampling (q 10 min), for 12–24 h, to assess LH levels.
The presence of LH pulses was determined by a modification of the
method of Santen and Bardin (16, 17), as previously described. Indi-
viduals were considered as having apulsatile LH secretion if they had
1 peak or less in 24 h, and low amplitude LH secretion if the mean
amplitude was less than 2 sds of mean LH amplitude of 10.2 6 1.8 IU/L,
as identified in 20 normal men (10). All immunoassays were performed
according to previously published methods (10, 16).
Results
Pedigree characteristics
Of the 101 IHH probands evaluated, 59 were anosmic (KS),
whereas 42 had a normal sense of smell (IHH) (Table 1). Of
the 59 KS cases, 21 were familial. By pedigree inspection, only
a single family seemed X-linked (i.e. only affected males in
multiple generations and females as obligate carriers). Eight
families had vertical transmission of partial or complete KS
phenotypes, suggesting dominant transmission. In 6 of 8
pedigrees, probands with complete KS had family members
in preceding generations with only isolated anosmia but
normal reproductive function. In another 6 families, affected
individuals included both affected males and females within
sibships; 2 of these families were also notable for consan-
guinity, suggesting an autosomal recessive mode of inheri-
tance. An additional 6 families consisted of 2 or more affected
brothers in a single sibship without affected females; these
families were labeled as being indeterminate. Of the 42 IHH
cases with normal olfaction, 13 were familial. Pedigree in-
formation was not available for 6 of the 42 cases.
Correlations of genotype to pedigree characteristics
Using the dinucleotide repeat polymorphism downstream
from KAL, allele patterns eliminated linkage between KAL
and KS in 4 kindreds. Using TGGE and direct sequencing,
mutations in the KAL gene were found in only 2 subgroups:
11% (4 of 38) of sporadic KS cases and in 14% (3 of 21) of KS
familial cases (the single X-linked family and in 2 of 6 families
with only affected brothers). Stated alternatively, all families
with vertical transmission of a partial or complete KS phe-
notype and all families with affected males and females in a
single sibship were free of detectable KAL mutations. Sim-
ilarly, no mutations in the coding sequence of the KAL gene
were identified in any of the 42 nonanosmic IHH probands
nor in families in which both KS and normosmic IHH pa-
tients coexisted (n 5 2). Genetically proven female carriers of
KAL mutations in 3 families all had normal pubertal devel-
opment, with regular menstrual cycles and normal olfaction. T
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Conversely, kindreds with anosmic women who gave birth
to sons with KS did not harbor KAL mutations (n 5 3).
Mutations, polymorphisms, and genotype/
phenotype correlations
The four novel mutations in the KAL gene detected in the
present study (C172R, R1913, R4573, and delC@L600) are
depicted in Table 2 along with their phenotype, in addition
to mutations published previously by our group (19). All
were found in patients in whom hypogonadotropic hypo-
gonadism was accompanied by anosmia (Fig. 1). One mu-
tation corresponds to a T-to-C substitution at nucleotide 664
(TGT to CGT) in exon 4 (the WAP region), changing cysteine
into arginine at codon 172 (C172R). This mutation was found
in each of three brothers with KS. The second novel mutation
consists of a C-to-T substitution at nucleotide 721 in exon 5
(CGA to TGA) that changes an arginine into a stop at codon
191 (R1913) (fibronectin III repeat domain). This mutation
was detected in two cases of sporadic KS. In the third novel
mutation, a T substitutes for a C at nucleotide 1519, changing
codon 457 from an arginine to a stop codon (CGA to TGA,
R4573) (fibronectin III repeat domain). This mutation was
detected in two unrelated patients, one with sporadic KS and
the other with X-linked KS. The final mutation consists of a
single base deletion of a C at nucleotide 1951 (codon 600),
causing a frameshift in exon 12, and a stop codon (TAA) to
be introduced at position 618 (exon 13). This mutation was
identified in two brothers.
We also found two previously described polymorphisms
(20). The first is a substitution of an A for a G at codon 534,
changing valine into isoleucine. This change was identified
in 67% of our population, a somewhat higher percentage,
compared with previous reports of 48% in normals (20). The
second polymorphism is a T-to-C substitution in exon 12 at
codon 611 that was detected in 32% of our patients. This
conservative base pair change (isoleucine) has been previ-
ously identified in 24% of controls (20). Polymorphisms pre-
viously described in exons 2, 13, and 14 (19, 20) were not
detected in our population.
The clinical characteristics of the patients with KAL mu-
tations are described in Table 2. Individuals with the same
mutation presented with different phenotypes, even within
the same family. For example, two unrelated KS individuals
presented with the same mutation in exon 5 (R1913) but
different phenotypes. One patient was born with microphal-
lus and bilateral cryptorchidism (patient 3), whereas the
other individual had only right cryptorchidism (patient 2).
Lack of concordance between genotype and phenotype was
also observed within families. In the KS family with three
affected brothers all harboring the C172R mutation, synki-
nesia was present in all three, bilateral cryptorchidism was
present in two, but only one brother had unilateral renal
aplasia.
Neuroendocrine patterns of secretion
Thirty-seven individuals who underwent mutation anal-
ysis, as described here and in a previous report by our group
(19), underwent frequent blood sampling (21 KS and 16
IHH). Seventy-three percent (n 5 27) exhibited an apulsatile
pattern of LH secretion (#1 LH peak in 24 h), and 27% (n 5
10) presented with low amplitude pulses (three or more
pulses in 24 h) (Table 1). All individuals bearing KAL mu-
tations that were studied with frequent blood sampling (n 5
8) demonstrated an apulsatile pattern of LH secretion. Three
of these eight individuals were members of the same family.
Figure 2 shows the data for three representative individuals.
A shows a proband (patient 5 in Table 1) from an X-linked
pedigree with a documented KAL mutation (splice mutation
at Asn400) and with an apulsatile pattern of LH secretion
during a q 10-min blood sampling study. B shows a proband
from a familial KS pedigree, albeit indeterminate in its mode
of inheritance, with no KAL coding sequence mutation. The
pattern of LH secretion for this proband is again apulsatile
but with some possible evidence of LH secretion. C shows a
male proband from an autosomal dominant pedigree with no
detectable KAL coding sequence mutation. However, the
neuroendocrine profile of this proband demonstrates not
only measurable LH levels but also two LH pulses.
FIG. 1. KAL gene mutations and anos-
min. Schematic representation of the
KAL gene, indicating the mutations de-
scribed in the literature (arrows above
the gene) and the novel mutations re-
ported in the present study (arrows be-
low the gene), in relation to anosmin
structure.
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Discussion
This study supports and quantifies the importance of au-
tosomal genes in producing KS. Whereas much attention has
been focused upon the discovery, analysis, and clinical fea-
tures of cases with the X-linked form of KS, this study makes
it clear that most cases of familial (and presumably sporadic)
KS are either autosomal dominant or recessive in their eti-
ology. It is also clear that there are striking phenotypic dif-
ferences between those with mutations in the KAL gene and
those with autosomal modes of inheritance.
Of the 101 probands, 59 of which were anosmic and 21 of
59 which were familial, only a minority of the kindreds had
a pedigree consistent with X-linkage. However, it was the-
oretically possible that KS caused by KAL mutations might
include a more variable phenotype; hence, a comprehensive
mutational screening approach was taken to address this
issue. However, this study does not support the expansion
of the X-linked KS phenotype to include patients with IHH
with normal olfaction, families in which individuals with
normal and impaired sense of smell coexist, nor a female
carrier state in which anosmia/hyposmia or reproductive
abnormalities occur. However, X-linked cases with con-
firmed mutations in KAL did exhibit a spectrum of pheno-
types both within and across families with identical geno-
types. In addition, they all demonstrated a complete absence
of LH pulsations during frequent blood sampling. Given the
evidence of failure of GnRH neurons to migrate beyond the
cribiform plate in a single case of KS in whom a KAL gene
defect was confirmed (4), this complete absence of GnRH-
induced LH pulses fits with the failure of these neurons to
arrive in the medial basal hypothalamus and thus participate
in the induction of pulsatile LH secretion. Conversely, the
presence of low-amplitude LH pulses in autosomal cases
documents some degree of GnRH secretion. Thus, the neu-
roendocrine profiles should be considered as an additional
intermediary phenotype in this complex disorder. For the
moment, the genes underlying the autosomal cases of KS
remain to be discovered.
FIG. 2. LH secretion in KS. A, B, and C, Baseline secretory pattern of LH in three individuals with KS (arrow) assessed at 10-min intervals;
shaded area, lower limit of range of serum LH concentrations defined in normal men (35); T, serum testosterone measured in pooled samples
constituted from equal aliquots of the frequent blood samples; TV, testicular volumes recorded using a Prader orchidometer; inverted triangles,
LH pulses.
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Our findings demonstrate that the frequency of mutations
in the coding sequence of the KAL gene is low in both familial
and sporadic Kallmann patients. Whereas coding sequence
mutations in the KAL gene have previously been reported in
as many as 50–60% of familial cases (5, 6, 20), these inves-
tigators have largely focused upon X-linked kindreds. How-
ever, the mode of inheritance of pedigrees included in these
prior studies has occasionally been ambiguous (5). In addi-
tion, at least three families with apparent X-linked inheri-
tance have been reported with no KAL coding sequence
mutations, suggesting that mutations may occur in noncod-
ing regions of the KAL gene (5, 6). However, polymorphic
allele patterns of these pedigrees were not examined to de-
termine that these kindreds were, in fact, linked to the KAL
locus. Therefore, the formal possibilities remain that another
X-linked gene causes KS or that these families were not truly
X-linked. Nevertheless, our finding of only three KAL mu-
tations in the entire cohort of anosmic familial cases (n 5 21),
combined with other pedigree features, certainly demon-
strates that the majority of familial KS is attributable to au-
tosomal (and not X-linked) genes.
Since the KAL gene escapes X inactivation, obligate carrier
mothers of KS patients harbor both normal and mutated
alleles. The presumption that these women have a decrease
in anosmin levels raises the possibility of a partial phenotype
in either reproductive or olfactory function. Partial expres-
sion of X-linked diseases in female carriers has been de-
scribed in numerous conditions (21–24). In fact, our group
has described female carriers in another X-linked form of
hypogonadotropic hypogonadism (congenital adrenal hypo-
plasia) with a reproductive phenotype (25). Previous studies
have never clearly addressed whether KAL mutations may be
present in normosomic patients. Kirk et al. (26) performed
olfactory testing for KS in eight female carriers who were
identified on the basis of the birth of an affected son. No
genetic data were available on these patients except for a
single family that was known to harbor a 7Mb interstitial
deletion on Xp. As a group, the female KS carriers had a
lower median threshold for detection of all odorant classes,
compared with the control groups. However, considerable
overlap of the KS carriers with unaffected relatives was ap-
parent. Nonetheless, these authors concluded that obligate
female carriers were hyposmic, but with considerable over-
lap with normals, making olfactory testing unsatisfactory for
detection of carrier status.
Therefore, this study sought to examine whether anosmic
women with normal reproductive function might actually
have KAL mutations. We evaluated three families in which
anosmic women gave birth to sons with KS, and none had
any mutation in the coding sequence of the KAL gene. Con-
versely, three obligate female KAL mutant carriers, identified
in our screening program, had no olfactory defect by history
(although formal testing was not performed). The absence of
documented mutations in the KAL coding sequence in
women with anosmia in KS families and the apparently
normal olfactory function in female carriers with docu-
mented KAL mutations provide additional evidence against
isolated anosmia being a partial phenotype of KAL muta-
tions. The occurrence of isolated anosmia (without IHH) as
an alternative phenotypic manifestation of the same genetic
defect within a given KS family thus seems to be a feature of
the autosomal dominant cases that demonstrates variable
expressivity.
In addition to examining isolated anosmia as a possible
surrogate marker for KAL mutations, we also examined the
possibility that normosmic IHH might be a partial phenotype
for KS. However, two pedigrees in which siblings had both
IHH and KS also did not exhibit a KAL mutation.
Variable expression of other phenotypic features associ-
ated with KS (i.e. synkinesia, renal agenesis, and cryptorchid-
ism) has been well documented. However, neuroendocrine
profiles of LH secretion have not been reported in detail for
this condition. Previous studies have shown that the GnRH
neurons originate in the olfactory placode and migrate into
the brain along branches of the terminalis and vomeronasal
nerves (27). Schwanzel-Fukuda et al. (4) studied a KS fetus
with a deletion from Xp 22.31 to Xpter, i.e. encompassing
the entire KAL gene, and demonstrated that migration of the
GnRH and olfactory neurons was arrested just below the
telencephalon at the cribiform plate. No GnRH expression in
cells or fibers was detected in the brain, yet dense clusters of
GnRH cells and thick fascicles of GnRH fibers remained in
the nose. Mutations in KAL (and by extension, anosmin)
seem to cause premature failure of migration of the olfactory
neurons and, consequently, of the GnRH neurons to the
brain. We demonstrated that eight patients with mutations
in the coding sequence of the KAL gene that were studied
with 10-min blood sampling exhibited uniformly apulsatile
patterns of LH secretion and, by extension, a complete ab-
sence of GnRH secretion. Though other familial cases may
also demonstrate an apulsatile pattern, we identified a fa-
milial, non-X-linked case that had evidence of low-amplitude
LH pulses (Fig. 1). Thus, it seems that some non-X-linked KS
cases may not be attributable to abnormalities in GnRH mi-
gration, having some GnRH-induced LH signaling, albeit
attenuated, present. Obviously, additional neuroendocrine
studies are required to address this issue. Interestingly, how-
ever, at least by the data presented in this study, apulsatile
LH secretion may be one of the more consistent phenotypic
features of KS attributable to KAL mutations.
Previously described mutations in the KAL gene are dis-
tributed throughout the gene, although most point muta-
tions cluster in the four fibronectin type III repeat (FNIII)
domains (Fig. 1) (5, 6, 19, 20, 28–31). However, mutations in
the cysteine-rich region were also published in KS patients
presenting with synkinesia and renal malformations, the
most common nonreproductive abnormalities associated
with this syndrome. The C172R mutation described in the
WAP-region was identified in a family with three KS broth-
ers, all of whom presented with synkinesia in addition to
their reproductive disorder. One brother in this family also
had unilateral renal aplasia, as described previously for mu-
tations in the FNIII region. Two unrelated patients with the
KAL mutation, W2583, have been reported (6); one had
bimanual synkinesia, left renal aplasia, and cryptorchidism
whereas the other had no such phenotypic anomalies. Hard-
elin et al. (5) described another patient with the same W2583
mutation, presenting with synkinesia and unilateral renal
aplasia but no cryptorchidism. Thus, there seems to be ex-
tensive variability in the phenotypic expression of mutations
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both within and between families (2, 5, 6, 19, 20, 28, 30–34).
Even though the mutations are more frequently located in the
FNIII region, there do not seem to be hot spots in the KAL
gene. There is also no correlation between phenotype and
location of the mutation (5).
In summary, a small proportion of both familial and spo-
radic cases of KS carry KAL mutations. Considering just the
familial cases, KAL mutations were identified only in families
that were clearly X-linked or in which only brothers were
affected. No mutations were found in nonanosmic IHH pa-
tients in families with both IHH and KS patients or in families
with anosmic women with normal reproductive function
and KS males. In our small population of genetically proven
female carriers, anosmia does not seem to represent a partial
phenotype. Affected individuals with KAL gene mutations
have apulsatile LH secretion. Autosomal genes causing KS
exist, seem to account for the majority of cases, and may have
unique neuroendocrine phenotypes.
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